A new research paper titled "ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines" has been published in Oncotarget.
Jan 17, 2024
0
0
A new editorial paper was published in Oncotarget titled, "Reductive carboxylation of glutamine as a potential target in acute myeloid leukemia."
Jan 16, 2024
0
0
Three weeks after her 40th birthday, Julie McDonald had a colonoscopy. When she walked into the doctor's office afterwards, there were photos lined up on the desk.
Jan 11, 2024
0
1
There is an unresolved debate about the extent to which the environment contributes to cancer risk. Although epidemiological studies suggest that environmental factors such as diet can certainly contribute, especially for ...
Jan 11, 2024
0
0
Soy compounds called isoflavones are among the plant-derived compounds that may significantly reduce the risk of breast cancer recurrence or death, according to a new meta-analysis co-directed by investigators from the Johns ...
Jan 10, 2024
0
1
As the cause of chronic inflammatory bowel diseases (IBD) such as Crohn's disease or ulcerative colitis is not yet known, treatment for sufferers is currently aimed at alleviating the often agonizing symptoms. The discovery ...
Jan 10, 2024
0
14
With tens of thousands of synthetic chemicals on the market, and new ones in development all the time, knowing which ones might be harmful is a challenge both for the federal agencies that regulate them and the companies ...
Jan 10, 2024
2
60
Cutaneous melanoma is considered the deadliest form of skin cancer because it's aggressive and tends to spread quickly through the body. While scientists have made significant progress in understanding the molecular mechanisms ...
Jan 9, 2024
0
0
Thirty years ago, Gail Sonenshein was studying cancer in immune cells when she read an article in the New York Times that would shape the rest of her career. The article described a new residency program in women's health, ...
Jan 9, 2024
0
0
A new Cleveland Clinic study shows there are disparities in cancer research and advocacy funding and that less funding strongly correlates with fewer clinical trials in a particular disease.
Jan 9, 2024
0
0
